羽田真郎先生の論文がJpn J Clin Oncolにアクセプトされました！
Congratulations !
A clinical risk model predicts over 300 ILD-free days in urological cancer patients on immune checkpoint inhibitors.
Hata S, Abe S, Fujinami H, Sato Y, Yamanaka N, Shin T.
Jpn J Clin Oncol.2026 Jul 20:hyag114. doi: 10.1093/jjco/hyag114.